Ken Griffin's top holdings (August 2025) include Charles Schwab Corp. (SCHW), a leading provider of brokerage, banking, and financial advisory services.

Ken Griffin is the founder and CEO of Citadel, a global investment firm. Under his leadership, Citadel operates across a wide range of investment strategies, including equities, fixed income, and commodities. The firm is known for its data-driven approach and extensive market research.

Charles Schwab Corp. (SCHW)

Charles Schwab Corp. is a well-known financial services company that provides a broad range of investing, wealth management, and banking solutions to individual and institutional clients. Its offerings include brokerage services, banking products, and financial advice, catering to millions of customers across the globe. The company commands a market capitalization of approximately $176.36 billion. Ken Griffin's position in Charles Schwab Corp. is currently valued at $2.0 billion. Analysts have set a price target of $100.5 for the company, while its discounted cash flow analysis suggests a value of $141.22 per share.
Here's an overview of Ken Griffin's trades in Charles Schwab Corp.:

Invesco Capital Management LLC - Invesco QQQ Trust Series 1 (QQQ)

The Invesco QQQ Trust Series 1 is an exchange-traded fund (ETF) that tracks the Nasdaq-100 Index, which includes 100 of the largest domestic and international non-financial companies listed on the Nasdaq Stock Market. This ETF is widely used by investors seeking exposure to large-cap growth companies, particularly in the technology sector. The Invesco QQQ Trust has a market capitalization of $15.29 million. This holding in Ken Griffin's portfolio is currently worth $1.37 billion.
Here's an overview of Ken Griffin's trades in Invesco Capital Management LLC - Invesco QQQ Trust Series 1:

Hess Corporation (HES)

Hess Corporation is a global independent energy company engaged in the exploration and production of crude oil and natural gas. The company operates in key oil and gas producing regions around the world, focusing on strategic, long-term assets. Its primary business involves discovering, developing, producing, transporting, and marketing crude oil and natural gas. With a market capitalization of $46.07 billion, Hess Corporation is a significant player in the energy sector. The current value of Ken Griffin's position in Hess Corporation is $1.25 billion. Analysts have established a price target of $159.0, while discounted cash flow analysis indicates a value of $111.12 per share.
Here's an overview of Ken Griffin's trades in Hess Corporation:

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corporation is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. The company is best known for its transcatheter aortic valve replacement (TAVR) technology, which offers minimally invasive options for patients with severe aortic stenosis. Its products are widely used in hospitals worldwide to improve patient outcomes. Edwards Lifesciences Corp has a market capitalization of $46.93 billion, and Ken Griffin's position in the company is currently valued at $1.06 billion. The discounted cash flow value for Edwards Lifesciences is $34.31 per share, and analysts have set a price target of $75.0.
Here's an overview of Ken Griffin's trades in Edwards Lifesciences Corp:

Medtronic Plc (MDT)

Medtronic Plc is a global healthcare technology leader, developing and manufacturing a wide range of medical devices and therapies. The company operates across various segments, including cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes. Medtronic's innovations aim to alleviate pain, restore health, and extend life for millions of people worldwide. The company's market cap stands at $119.08 billion. Ken Griffin's holding in Medtronic Plc is currently worth $781.58 million. The discounted cash flow analysis suggests a value of $120.65 per share.
Here's an overview of Ken Griffin's trades in Medtronic Plc: